Medication info

Janidin Tablet (Lercanidipine Hydrochloride)

Prescription medicationExpired
Ingredient · strength
Lercanidipine Hydrochloride›Strength being verified
Manufacturer / importer
CMG Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201308390 · Approved 2013.07.25

This product's status changed to Expired on 2023.07.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of mild to moderate essential hypertension
Who uses it
Adults
Adult dosage
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg depending on the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become evident. For patients whose blood pressure is not controlled with this medicine, it may be used in combination with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg. Therefore, higher doses do not increase the effect and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that no adjustment of the daily dose is needed; however, caution is necessary when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Special caution is required when initiating treatment in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen is the same for these patients, caution is required when increasing the daily dose to 20 mg. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, and dose adjustment should be considered. This medicine should not be administered to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
CMG Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension, or high blood pressure, refers to a condition where blood pressure persists above the normal range. This medicine is used to control blood pressure in patients with mild to moderate essential hypertension to reduce the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg depending on the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become evident. For patients whose blood pressure is not controlled with this medicine, it may be used in combination with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg. Therefore, higher doses do not increase the effect and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that no adjustment of the daily dose is needed; however, caution is necessary when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Special caution is required when initiating treatment in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen is the same for these patients, caution is required when increasing the daily dose to 20 mg. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, and dose adjustment should be considered. This medicine should not be administered to patients with severe hepatic or renal impairment.

Precautions

This medicine should not be used in certain patients. For example, people who are allergic to this medicine or similar medications, women who are pregnant or may become pregnant, and women who are nursing should not take this medicine. Additionally, patients with heart problems, very poor liver or kidney function, those who have recently experienced a myocardial infarction, patients on dialysis, and children or adolescents under the age of 18 should also not use this medication. This medicine contains lactose, so individuals with lactose intolerance or related genetic diseases should avoid using it. Caution is necessary when using this medicine for some patients. For instance, patients with cardiac rhythm control issues, those with weak heart function, mild to moderate liver or kidney disease, patients with a history of angina, individuals who consume alcohol frequently, and the elderly should use this medicine carefully. During treatment, side effects such as facial flushing, edema, palpitations, dizziness, headache, and indigestion may occur. If any signs of liver dysfunction appear, consult a doctor immediately. Suddenly discontinuing this medicine may worsen symptoms, so the dosage should be gradually reduced while closely monitoring the condition. Moreover, because this medicine is metabolized in the liver, interactions with certain medications can alter its effectiveness. It is particularly crucial to exercise caution when combined with medications affecting liver enzymes, such as certain antifungals, antibiotics, anticonvulsants, and immunosuppressants. Women who are pregnant or breastfeeding are advised against taking this medicine due to reports in animal studies suggesting potential harm to the fetus. The safety and efficacy of this medicine have not been established in children and adolescents, hence it is not prescribed for them. The elderly require special attention while taking this medicine, and dosage adjustments may be necessary. In cases of overdose, severe hypotension and arrhythmias may occur, necessitating immediate medical attention and at least 24 hours of cardiovascular monitoring. Finally, store this medicine out of reach of children, and it is important to keep it in its original packaging to maintain quality.

Side effects

Flushing, peripheral edema, palpitations, tachycardia, hypotension, chest pain, angina, headache, dizziness, weakness, fatigue, drowsiness, neurosis, dyspepsia, nausea, vomiting, abdominal pain, diarrhea, elevated serum levels of liver aminotransferases, polyuria, increased urinary frequency, gingival hyperplasia, rash, myalgia, body tremors, insomnia, dry mouth, hand tingling, cough, abdominal bloating, erectile dysfunction, arrhythmia, cold sweats, skin tingling, premature contractions, tongue stiffness, increased ventricular premature beats, shortness of breath, gastrointestinal disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Avoid very hot or very cold places, and it is best to store it at a normal temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.